In 2023, the import of insulin to Canada was positioned lower than forecasted figures for subsequent years. From 2024 to 2028, the import values are predicted to rise consistently, with an average annual increase in value (CAGR) observed. Year-on-year analysis illustrates upward trends, escalating from approximately 940.43 thousand US dollars in 2024 to 1060.9 thousand US dollars in 2028. This demonstrates a robust growth trajectory anticipated in the coming years.

Future trends to watch for include:

Technological advancements in insulin production impacting import needs.
Potential shifts in healthcare policies influencing market demand and supply chain dynamics.
Emergence of new competitors or partnerships altering market structure.